处方监测计划授权和阿片类药物发放给因癌症死亡的患者
Yuhua Bao1, Hao Zhang2, Laura C Pinheiro3
1Department of Population Health Sciences, Weill Cornell Medicine, New York, NY.
JCO oncology practice
|January 8, 2026
概括
要求处方药监测计划 (PDMPs) 的州法律适度减少了癌症患者临终期的阿片类药物使用. 黑人和亚洲/太平洋岛民患者的减少幅度更大.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 要求处方者使用处方药监测计划 (PDMPs) 的州立法可能会影响晚期癌症患者获得阿片类止痛药的机会.
- 了解这些影响对于公平的终身护理至关重要.
研究的目的:
- 评估全面的PDMP任务与Medicare癌症死亡患者的阿片类药物相关结果之间的关联.
- 检查这些由已故的种族和种族分层的协会.
主要方法:
- 使用SEER-Medicare数据 (2011-2019) 对66岁以上患有癌症的已故患者进行的横截面研究.
- 差异差异设计比较具有和没有全面PDMP授权的州.
- 结果包括阿片类药物服用日数和临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终期临终线线直线模型被使用.
主要成果:
- 全面的PDMP任务与阿片类药物日和总/每日MME的适度减少有关.
- 一天或多天服用阿片类药物的比例从45.1%降至43.9%.
- 与白人死者相比,黑人和亚洲/太平洋岛屿居民的死者在阿片类药物日数中出现了不成比例地更大的减少.
结论:
- 全面的PDMP授权与对Medicare癌症死者的阿片类药物处方的适度减少有关.
- 这些任务似乎对减少黑人和亚洲/太平洋岛民人口中阿片类药物使用的影响更大.
相关概念视频
01:02Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
01:29Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
841
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
841
01:16Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
172
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
172